All Research Papers Published In Chinese Journal of Clinical Oncology

Export

Sort by: Relevance

Supplementary Content
10.12354/j.issn.1000-8179.2025.20241435

Establishment and clinical applications of a prognostic model based on disease progression within 24 months in patients with multiple myeloma

Jan 1, 2025
Chinese Journal of Clinical Oncology
Gong, Y + 4 more

Supplementary Content
10.12354/j.issn.1000-8179.2024.20231246

Research progress on protein glycosylation modification in colorectal cancer

Jan 1, 2024
Chinese Journal of Clinical Oncology
Xiaofan, L + 1 more

Supplementary Content
10.12354/j.issn.1000-8179.2024.20241413

New progress in immunotherapy of solid tumors targeting B7-H3

Jan 1, 2024
Chinese Journal of Clinical Oncology
Shuo, W + 5 more

Supplementary Content
10.12354/j.issn.1000-8179.2023.20230237

Research progress on neurotransmitters in malignant brain tumors based on microbiota-gut-brain axis

Jan 1, 2023
Chinese Journal of Clinical Oncology
Fei, L + 2 more

Supplementary Content
10.12354/j.issn.1000-8179.2023.20221098

Analysis of opportunistic screening of upper gastrointestinal cancer in Zhejiang Province in 2019-2021

Jan 1, 2023
Chinese Journal of Clinical Oncology
Huang, W + 7 more

Supplementary Content
10.12354/j.issn.1000-8179.2023.20230381

Research progress on interstitial pneumonia following lymphoma therapy

Jan 1, 2023
Chinese Journal of Clinical Oncology
Cheng, M + 2 more

Supplementary Content
10.12354/j.issn.1000-8179.2023.20221711

A national multicenter retrospective clinical study to develop a prognostic nomogram for patients with esophageal squamous cell carcinoma based on definitive radiotherapy (3JECROG R-03A)

Jan 1, 2023
Chinese Journal of Clinical Oncology
Yu, L + 28 more

Supplementary Content
10.12354/j.issn.1000-8179.2023.20221748

Progress and prospect of diagnosis and treatment of cancers of unknown primary

Jan 1, 2023
Chinese Journal of Clinical Oncology
Bowen, H + 4 more

Research Article
10.1007/s11805-009-0059-1

Analysis of efficacy of DICE (dexamethasone, ifosfamide, cisplatin and etoposide) regimen on recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma

Feb 1, 2009
Chinese Journal of Clinical Oncology
Lei Yang + 6 more

Objective Thus far there is no standard salvage regimen for patients with recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma (NHL). This study intends to investigate the therapeutic efficacy of the DICE (dexamethasone, isofosfamide, cisplatin and etoposide) regimen on the recurrent and refractory NHL, and to observe the related adverse effects.

Research Article
10.1007/s11805-009-0047-5

Study on fractionated total body irradiation before hematopoietic stem cell transplantation

Feb 1, 2009
Chinese Journal of Clinical Oncology
Tong Fang + 2 more

Objective To observe the dose and the complications from total body irradiation before hematopoietic stem cell transplantation.